Denali Therapeutics Inc.
DNLI | NASDAQ
$21.48
+$1.01 (+4.93%)
Sep 22, 2026, 1:39 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27M | 294.12M | 35.14M | 10.28M | 3.56M | 52.48M | 42.14M | 12.51M | 5.29M | 22.94M | 7.92M |
Cost of Revenue | n/a | 2.85M | 2.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -2.85M | -2.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27M | 294.12M | 35.14M | 10.28M | 3.56M | 52.48M | 42.14M | 12.51M | 5.29M | 22.94M | 7.92M |
Operating Income | -130.54M | -137.36M | -137.37M | -137.43M | -134.96M | -145.58M | -129.85M | -123.19M | -116.59M | -117.72M | -132.57M | -113.8M | 170.48M | -120.82M | -105.34M | -107.49M | -61.42M | -66.5M | -77.12M | -85.59M | -61.82M | -71.22M |
Interest Income | n/a | 8.91M | 8.92M | 10.53M | 10.84M | 12.61M | 15.16M | 16M | 17.57M | 15.91M | 13.13M | 14.44M | 12.9M | 11.03M | 6.66M | 4.19M | 2.65M | 1.28M | 1.29M | 1.01M | 1.13M | 1.18M |
Pretax Income | -127.55M | -128.45M | -128.45M | -126.9M | -124.12M | -132.97M | -114.69M | -107.19M | -99.03M | -101.8M | -119.44M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.77M | -65.22M | -75.84M | -84.59M | -60.69M | -70.04M |
Net Income | -127.55M | -128.45M | -128.55M | -126.9M | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M | -84.59M | -60.69M | -70.04M |
Selling & General & Admin | 36.28M | 30.67M | 36.59M | 35.48M | 32.27M | 29.35M | 30.06M | 24.95M | 25.19M | 25.24M | 24.77M | 25.33M | 26.12M | 27.14M | 23.52M | 23.26M | 21.16M | 22.54M | 21.76M | 19.32M | 19.05M | 18.94M |
Research & Development | 97.02M | 103.85M | 97.91M | 101.95M | 102.7M | 116.23M | 99.79M | 98.24M | 91.4M | 107.02M | 107.8M | 89.74M | 97.52M | 128.82M | 92.11M | 87.79M | 92.74M | 86.1M | 67.88M | 71.56M | 65.71M | 60.21M |
Other Expenses | 843K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 134.15M | 134.51M | 134.5M | 137.43M | 134.96M | 145.58M | 129.85M | 123.19M | 116.59M | 117.72M | 132.57M | 115.06M | 123.64M | 155.96M | 115.63M | 111.05M | 113.9M | 108.64M | 89.64M | 90.88M | 84.76M | 79.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 137.36M | 137.37M | 137.43M | 134.96M | 145.58M | 129.85M | 123.19M | 116.59M | 117.72M | 132.57M | 115.06M | 123.64M | 155.96M | 115.63M | 111.05M | 113.9M | 108.64M | 89.64M | 90.88M | 84.76M | 79.14M |
Income Tax Expense | n/a | n/a | 102K | n/a | n/a | n/a | 68K | n/a | n/a | n/a | 30K | n/a | n/a | n/a | -6K | n/a | 27K | n/a | -575K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 137.05M | 136.52M | 132.88M | 123.47M | 122.49M | 122.67M | 122.16M | 121.74M | 121.29M | 120.76M |
Shares Outstanding (Diluted) | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 140.93M | 136.52M | 132.88M | 123.47M | 123.01M | 122.67M | 122.16M | 121.74M | 123.01M | 120.88M |
EPS (Basic) | -0.68 | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.80 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.50 | -0.58 |
EPS (Diluted) | -0.68 | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.30 | -0.80 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.49 | -0.58 |
EBITDA | -130.54M | -125.6M | -124.67M | -123.04M | -120.16M | -129.76M | -112.07M | -104.92M | -97.08M | -130.09M | -117.27M | -97.14M | 185.67M | -99.73M | -94.59M | -101.16M | -56.7M | -63.14M | -73.74M | -82.4M | -58.49M | -69.11M |
EBIT | n/a | -128.45M | -128.45M | -126.9M | -124.12M | -132.97M | -114.69M | -107.19M | -99.03M | -132.25M | -119.44M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.77M | -65.22M | -75.84M | -84.59M | -60.69M | -71.22M |
Depreciation & Amortization | n/a | 2.85M | 3.78M | 3.86M | 3.96M | 3.21M | 2.62M | 2.27M | 1.94M | 2.16M | 2.18M | 2.22M | 2.29M | 10.05M | 4.09M | 2.14M | 2.07M | 2.08M | 2.09M | 2.19M | 2.2M | 2.11M |
Add to Watchlist
Select watchlists to add or remove DNLI